M. Breidert et al., PREVALENCE OF DIABETES-SPECIFIC AUTOANTIBODIES IN PATIENTS AT RISK FOR ADULT-ONSET DIABETES-MELLITUS, EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 106(2), 1998, pp. 113-116
To evaluate the potential of autoimmune markers in identifying patient
s with slowly progressive IDDM in the prediabetic state, we screened a
population of 151 patients aged 37-70 years with impaired glucose tol
erance (IGT) for the presence of islet cell antibodies (ICA), insulin
autoantibodies (IAA), antibodies to glutamic acid decarboxylase (GADA)
, and antibodies to tyrosine phosphatase IA-2 (IA-2A). Autoantibodies
were found in 5 (3.3%) patients with IGT suggesting the presence of an
autoimmune-mediated Beta cell destruction. All of them were positive
for high level ICA (>20 JDF-U) and 1 ICA positive subject had addition
al GADA (100 GADA-U). In contrast, none of the subjects had IA-2A or I
AA. We here demonstrate a low prevalence of autoimmune diabetes among
middle-aged subjects with IGT. ICA and GADA but not IA-2A or IAA may r
epresent autoimmune markers for slowly progressive IDDM before the man
ifestation of the disease.